Raffaele Colombo

898 total citations · 1 hit paper
33 papers, 652 citations indexed

About

Raffaele Colombo is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Raffaele Colombo has authored 33 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Raffaele Colombo's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (10 papers) and Chemical Synthesis and Analysis (6 papers). Raffaele Colombo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (10 papers) and Chemical Synthesis and Analysis (6 papers). Raffaele Colombo collaborates with scholars based in Italy, United States and Slovakia. Raffaele Colombo's co-authors include Jamie R. Rich, Umberto Piarulli, Cesare Gennari, Mario Anastasia, Pietro Allevi, Paola Rota, Paolo Tarantino, Elisabeth G.E. de Vries, Patricia LoRusso and Luca Pignataro and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Raffaele Colombo

31 papers receiving 637 citations

Hit Papers

The Journey of Antibody–Drug Conjugates: Lessons Learned ... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raffaele Colombo Italy 16 321 220 206 153 77 33 652
Andreas F. B. Räder Germany 11 509 1.6× 196 0.9× 177 0.9× 119 0.8× 184 2.4× 13 887
Michael Weinmüller Germany 11 509 1.6× 179 0.8× 201 1.0× 118 0.8× 177 2.3× 13 884
Aurélie Maisonial‐Besset France 16 237 0.7× 266 1.2× 84 0.4× 117 0.8× 29 0.4× 33 538
Victor Gonçalves France 20 488 1.5× 243 1.1× 243 1.2× 395 2.6× 35 0.5× 42 1.0k
Curtis Harwig Canada 17 286 0.9× 332 1.5× 199 1.0× 243 1.6× 28 0.4× 27 833
Ko‐Chung Lin United States 12 275 0.9× 223 1.0× 117 0.6× 134 0.9× 258 3.4× 13 736
Bernhard Stump Switzerland 10 359 1.1× 333 1.5× 291 1.4× 312 2.0× 17 0.2× 13 836
Alberto Dal Corso Italy 18 637 2.0× 316 1.4× 411 2.0× 378 2.5× 220 2.9× 39 1.0k
Dorin Toader United States 16 427 1.3× 327 1.5× 345 1.7× 296 1.9× 22 0.3× 44 1.0k
Michael A. Dechantsreiter Germany 10 690 2.1× 345 1.6× 179 0.9× 204 1.3× 415 5.4× 12 1.1k

Countries citing papers authored by Raffaele Colombo

Since Specialization
Citations

This map shows the geographic impact of Raffaele Colombo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffaele Colombo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffaele Colombo more than expected).

Fields of papers citing papers by Raffaele Colombo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffaele Colombo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffaele Colombo. The network helps show where Raffaele Colombo may publish in the future.

Co-authorship network of co-authors of Raffaele Colombo

This figure shows the co-authorship network connecting the top 25 collaborators of Raffaele Colombo. A scholar is included among the top collaborators of Raffaele Colombo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffaele Colombo. Raffaele Colombo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colombo, Raffaele, et al.. (2025). Beyond the Guided Missile Paradigm: Embracing the Complexity of Antibody-Drug Conjugates. Journal of Clinical Oncology. 43(31). 3339–3344.
2.
Colombo, Raffaele, et al.. (2024). The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development. Cancer Discovery. 14(11). 2089–2108. 65 indexed citations breakdown →
4.
Colombo, Raffaele, et al.. (2023). Abstract 2641: ZW191, a novel FRa-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload. Cancer Research. 83(7_Supplement). 2641–2641. 3 indexed citations
5.
Madera, Laurence, Raffaele Colombo, Alexander T.H. Wu, et al.. (2023). Abstract 2658: ZW251, a novel glypican-3-targeting antibody drug conjugate bearing a topoisomerase 1 inhibitor payload. Cancer Research. 83(7_Supplement). 2658–2658. 2 indexed citations
7.
Colombo, Raffaele. (2023). Abstract IA003: Refining our understanding of ADCs: Drug development insights from 40 years of data. Molecular Cancer Therapeutics. 22(12_Supplement). IA003–IA003. 1 indexed citations
8.
Colombo, Raffaele, et al.. (2022). Cyclopentadiene as a Multifunctional Reagent for Normal- and Inverse-Electron Demand Diels–Alder Bioconjugation. Bioconjugate Chemistry. 33(9). 1609–1619. 9 indexed citations
9.
Colombo, Raffaele & Jamie R. Rich. (2022). The therapeutic window of antibody drug conjugates: A dogma in need of revision. Cancer Cell. 40(11). 1255–1263. 103 indexed citations
10.
Colombo, Raffaele, Alexander Ma, Norman Peterson, et al.. (2020). Metabolite-Based Modification of Poly(l-lysine) for Improved Gene Delivery. Biomacromolecules. 21(9). 3596–3607. 20 indexed citations
11.
LaPorte, Matthew G., James C. Burnett, Raffaele Colombo, et al.. (2018). Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97. ACS Medicinal Chemistry Letters. 9(11). 1075–1081. 18 indexed citations
12.
LaPorte, Matthew G., Raffaele Colombo, Atefeh Garzan, et al.. (2016). Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(15). 3581–3585. 28 indexed citations
13.
Kiesel, Brian F., Robert A. Parise, Jianxia Guo, et al.. (2016). Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation. Cancer Chemotherapy and Pharmacology. 78(6). 1225–1235. 7 indexed citations
14.
Marchini, Mattia, Raffaele Colombo, Laura Belvisi, et al.. (2012). Cyclic RGD Peptidomimetics Containing Bifunctional Diketopiperazine Scaffolds as New Potent Integrin Ligands. Chemistry - A European Journal. 18(20). 6195–6207. 61 indexed citations
15.
Rota, Paola, et al.. (2010). General and Chemoselective N‐Transacylation of Secondary Amides by Means of Perfluorinated Anhydrides. Angewandte Chemie International Edition. 49(10). 1850–1853. 23 indexed citations
16.
Pignataro, Luca, et al.. (2010). PhthalaPhos: Chiral Supramolecular Ligands for Enantioselective Rhodium‐Catalyzed Hydrogenation Reactions. Angewandte Chemie International Edition. 49(37). 6633–6637. 38 indexed citations
17.
Allevi, Pietro, et al.. (2010). Chemoselective Synthesis of Sialic Acid 1,7-Lactones. The Journal of Organic Chemistry. 75(16). 5542–5548. 15 indexed citations
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026